Clinical Trial

Art Therapy in Progressive Supranuclear Palsy

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Our aim is to study the effect of art therapy for people with PSP, with a focus on alleviating the symptoms associated with PSP, enhancing the overall quality of life for patients, and reducing caregiver stress. Overall, through our collaborative efforts on this study, we hope to unlock the benefits of art therapy for this vulnerable patient population, ultimately improving their overall well-being and enhancing their quality of life.
Protocol Amendment History 1 change
minor Completion pushed: 2026-12-02 -> 2027-07-02 2026-08-07
Trial Details
NCT Number NCT06588673
Lead Sponsor Vanderbilt University Medical Center
Collaborators: CurePSP Foundation
Conditions Progressive Supranuclear Palsy
Enrollment 10 participants
Start Date 2025-01-14
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-07-02 (estimated)
Updated on ClinicalTrials.gov 2026-08-06